These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1642686

  • 1. Distribution of recombinant human erythropoietin following multiple intravenous administration and effects of age on the distribution in rats.
    Kinoshita H, Ohishi N, Kato M, Tokura S, Okazaki A.
    Arzneimittelforschung; 1992 Apr; 42(4):579-84. PubMed ID: 1642686
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and distribution of recombinant erythropoietin in rats.
    Kinoshita H, Ohishi N, Kato M, Tokura S, Okazaki A.
    Arzneimittelforschung; 1992 Feb; 42(2):174-8. PubMed ID: 1610430
    [Abstract] [Full Text] [Related]

  • 3. Comparative pharmacokinetics and distribution of human urinary erythropoietin and recombinant human erythropoietin in rats.
    Kinoshita H, Ohishi N, Kato M, Tokura S, Okazaki A.
    Arzneimittelforschung; 1991 Sep; 41(9):1004-7. PubMed ID: 1796912
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and distribution of recombinant human erythropoietin in rats with renal dysfunction.
    Kinoshita H, Ohishi N, Tokura S, Okazaki A.
    Arzneimittelforschung; 1992 May; 42(5):682-6. PubMed ID: 1530684
    [Abstract] [Full Text] [Related]

  • 5. Mechanism for the nonlinear pharmacokinetics of erythropoietin in rats.
    Kato M, Kamiyama H, Okazaki A, Kumaki K, Kato Y, Sugiyama Y.
    J Pharmacol Exp Ther; 1997 Nov; 283(2):520-7. PubMed ID: 9353365
    [Abstract] [Full Text] [Related]

  • 6. Preparation of iodine labeled recombinant human erythropoietin.
    Kinoshita H, Ohishi N, Okazaki A.
    Arzneimittelforschung; 1991 May; 41(5):568-70. PubMed ID: 1898429
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of erythropoietin in genetically anemic mice.
    Kato M, Miura K, Kamiyama H, Okazaki A, Kumaki K, Kato Y, Sugiyama Y.
    Drug Metab Dispos; 1998 Feb; 26(2):126-31. PubMed ID: 9456298
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in rats.
    Kato M, Okano K, Sakamoto Y, Miura K, Uchimura T, Saito K.
    Arzneimittelforschung; 2001 Jan; 51(1):91-5. PubMed ID: 11215332
    [Abstract] [Full Text] [Related]

  • 9. Immunological response to repeated administration of recombinant human erythropoietin in rats: biphasic effect on its pharmacokinetics.
    Kato M, Miura K, Kamiyama H, Okazaki A, Kumaki K, Kato Y, Sugiyama Y.
    Drug Metab Dispos; 1997 Sep; 25(9):1039-44. PubMed ID: 9311618
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
    Yoon WH, Park SJ, Kim IC, Lee MG.
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of human activated protein C. 2nd communication: tissue distribution study of a lyophilized purified human activated protein C after single or repeated intravenous administration in male mice and placental transfer and milk passage study after intravenous administration in pregnant and lactating mice.
    Ishii S, Mochizuki T, Nagao T, Kudo S, Fujita A, Taniguchi K, Kondo S, Kiyoki M.
    Arzneimittelforschung; 1995 May; 45(5):644-56. PubMed ID: 7612069
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Binding of iodinated erythropoietin to rat bone marrow cells under normal and anemic conditions.
    Akahane K, Tojo A, Fukamachi H, Kitamura T, Saito T, Urabe A, Takaku F.
    Exp Hematol; 1989 Feb; 17(2):177-82. PubMed ID: 2536329
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic profile of recombinant human (rh) inhibin A and activin A in the immature rat. II. Tissue distribution of [125I]rh-inhibin A and [125I]rh-activin A in immature female and male rats.
    Woodruff TK, Krummen L, Chen SA, Lyon R, Hansen SE, DeGuzman G, Covello R, Mather J, Cossum P.
    Endocrinology; 1993 Feb; 132(2):725-34. PubMed ID: 8425491
    [Abstract] [Full Text] [Related]

  • 18. Responsiveness to recombinant human erythropoietin (rh-Epo) of marrow erythroid progenitors (CFU-E and BFU-E) from B-chronic lymphocytic leukemia (B-CLL).
    Tsatalas C, Chalkia P, Tsantali C, Kakoulidis I, Garyfallos A, Klonizakis I, Panayiotopoulos S.
    J Exp Clin Cancer Res; 1997 Jun; 16(2):163-70. PubMed ID: 9261742
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W, Goris H, Dontje B, Dresz J, Loeffler M.
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.